Search All UT System Experts

Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study

David E. Cohn, Michael W. Sill, Joan L. Walker, David O'Malley, Christa I. Nagel, Teresa L. Rutledge, William Bradley, Debra L. Richardson, Katherine M. Moxley, Carol Aghajanian

Research output: Contribution to journal › Article › peer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study'. Together they form a unique fingerprint.

Medicine & Life Sciences